A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer - Concepedia

Concepedia

Publication | Closed Access

A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer

47

Citations

20

References

2016

Year

Matthias Löhr, Masoud Karimi, Brigitta Omazic, Nikolaos Kartalis, Caroline S. Verbeke, Anders Berkenstam, Jan‐Erik Frödin

Escalation TrialPancreatic CancerMedicinePharmacologyAnti-cancer AgentCancer TreatmentUnresectable Pancreatic CancerOncologyRadiation OncologyChemotherapy-naive Patients

References

	Year	Citations

Page 1